Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology

Ops! No article found. Reset filter

Diagnostic diversity – an indicator of institutional and regional healthcare quality

Original article
Brutsche M, Rassouli F, Gallion H, Kalra S, Roger VL, Baty F
Swiss Med Wkly. 2018;148:w14691

The diagnostic diversity index can be seen as an indicator of diagnostic precision - the higher the degree of diversity, the better the diagnostic precision.

Dual use in the 21st century: emerging risks and global governance

Review article: Biomedical intelligence
Ienca M, Vayena E
Swiss Med Wkly. 2018;148:w14688

Dual use risks in the second decade of the 21st century are characterised by: diversification of dual use domains, digitalisation of potential threats, and the proliferation of actors.

A buyers’ club to improve access to hepatitis C treatment for vulnerable populations

Review article: Biomedical intelligence
Vernaz N, Calmy A, Hurst S, Jackson Y, Negro F, Perrier A, Wolff H
Swiss Med Wkly. 2018;148:w14649

High costs are an important barrier to treatment access for vulnerable and often uninsured patients with hepatitis C.

Predictors for shorter and longer length of hospital stay outliers: a retrospective case-control study of 8247 patients at a university hospital trauma department

Original article
Jentzsch T, Seifert B, Neuhaus V, Moos RM
Swiss Med Wkly. 2018;148:w14650

Providing efficient healthcare is important for hospitals. Shorter and longer length of hospital stay (LOS) outliers influence financial results and reimbursement.

The inconsistent ethical oversight of healthcare quality data in Switzerland

Viewpoint
McLennan S, Maritz R, Shaw D, Elger B
Swiss Med Wkly. 2018;148:w14637

Further consideration needs to be given to how regulations can be revised in a way that ensures that healthcare improvement activities using the same quality data in Switzerland are not either overregulated on one side or completely without control on the other.

Accidental or intentional exposure to potentially toxic medications, natural toxins and chemicals during pregnancy: analysis of data from Tox Info Suisse

Original article
Vogel T, Lüde S, Baumgartner R, Rauber-Lüthy C, Simões-Wüst AP
Swiss Med Wkly. 2018;148:w14620

Pregnant women are daily exposed to potentially harmful agents, such as food products and household chemicals, as well as medications. Affected women and health professionals are still often unsure about how to react.

Point prevalence of healthcare-associated infections and antibiotic use in three large Swiss acute-care hospitals

Original article
Metsini A, Vazquez M, Sommerstein R, Marschall J, Voide C, Troillet N, Gardiol C, Pittet D, Zingg W, the Swissnoso network
Swiss Med Wkly. 2018;148:w14617

The current burden of healthcare-associated infections (HAIs) in Switzerland is unknown. Prevalence surveys have a long tradition in the field of infection prevention and control for measuring both HAI and antimicrobial use.

The impact of clinical trial units on the value of clinical research in Switzerland

Review article: Biomedical intelligence
von Niederhäusern B, Magnin A, Pauli-Magnus C
Swiss Med Wkly. 2018;148:w14615

A decade ago, the Swiss National Science Foundation instigated clinical trial units (CTUs) at the five university hospitals and St Gallen cantonal hospital, with the aim of improving the quality of Swiss academic clinical research projects.

Diet, medication use and drug intake during pregnancy: data from the Swiss Health Surveys 2007 and 2012

Viewpoint
Koutelidakis A
Swiss Med Wkly. 2018;148:w14592

Adoption of a healthy lifestyle during pregnancy should remain a basic aim of national policies for health promotion and prevention of unexpected pregnancy outcomes.

Digital health: meeting the ethical and policy challenges

Review article: Biomedical intelligence
Vayena E, Haeusermann T, Adjekum A, Blasimme A
Swiss Med Wkly. 2018;148:w14571

Digital health entails connecting health-related data, including data generated by patients themselves, and harnessing the medical potential of technological tools of common usage, such as smartphones, wellness bands, apps, social media.

Verpassen Sie keinen Artikel!

close